Indian pharmaceutical companies are strategically pivoting their US market approach, deepening investments in high-value specialty drugs, complex therapies, and local manufacturing to counter pricing pressures and intensifying competition in ...
Mumbai: Zydus Lifesciences said it plans to launch the generic version of weight-loss injection semaglutide in prefilled cartridges of 15 mg and 3 ml dosage forms. The product, to ...
New Delhi: Zydus Lifesciences on Wednesday has received approval from the US health regulator to market a generic diabetes drug in the US market.The company has received tentative approval ...
New Delhi: Drug firm Lupin on Monday said it has launched a generic cancer treatment medication in the US.The company has launched Dasatinib Tablets in strengths of 20 mg, ...
IMAGE: Kindly note that this image has been posted for representational purposes only. Photograph: ANI Photo Citing public interest, the Delhi high court has cleared the way for Zydus ...
New Delhi, Glenmark Pharmaceuticals on Thursday said it will launch a generic medication this month in the US market for the treatment of anaemia and to prevent serious side ...
An expert committee has cleared Hyderabad-based drug major Dr Reddy’s Laboratories’ proposal to manufacture and market generic versions of blockbuster weight loss and obesity drug semaglutide.The company is aiming ...
Tamil Nadu-based Sresan Pharmaceuticals' cough syrup brand Coldrif that allegedly caused the deaths of more than 20 children in Madhya Pradesh is among thousands of generic cough syrup brands ...
Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health regulatory agency for its generic version of cancer treatment drug Ibrutinib tablets. The tentative ...
Drug firm Lupin on Wednesday said it has launched a generic medication to treat inflammation and pain in the eye. The company has launched Loteprednol Etabonate Ophthalmic Suspension, a ...